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Abstract
Background: Breast radiotherapy as practised in the 1970s and 1980s resulted in significant myocardial
exposure, and this was higher when the left breast was treated. It has been proposed that this difference
might result in greater cardiovascular mortality following irradiation of the left breast when compared with
the right.
Methods: All cases of female breast cancer diagnosed between 1971 and 1988 and recorded on the
Thames Cancer Registry database were followed up to the end of 2003 to identify cases who had died
from ischaemic heart disease (IHD) or any cardiovascular disease (CVD). A proportional hazards
regression analysis was performed, stratified by time since diagnosis, using as the baseline group those
women with right-sided disease who did not receive radiotherapy, and adjusting for age at diagnosis.
Results: A total of 20,871 women with breast cancer were included in the analysis, of which 51% had left-
sided disease. Mortality at 15+ years after diagnosis was increased in recipients of left-breast radiotherapy
compared to non-irradiated women with right-sided breast cancer, both for IHD (hazard ratio 1.59; 95%
confidence interval 1.21–2.08; p = 0.001) and all CVD (hazard ratio 1.27; 95% confidence interval 1.07–
1.51; p = 0.006). When irradiated women with left-sided breast cancer were compared with irradiated
women with right-sided breast cancer, cardiovascular mortality at 15+ years after diagnosis was raised by
around 25% (IHD: hazard ratio 1.23; 95% confidence interval 0.95–1.60; p = 0.114; CVD: hazard ratio 1.25;
95% confidence interval 1.05–1.49; p = 0.014).
Conclusion: We have found an elevation in cardiovascular mortality more than 15 years after breast
radiotherapy in women diagnosed with breast cancer between 1971 and 1988. The risk was greater
following irradiation of the left breast compared with the right. This confirms that radiotherapy as
practised in the 1970s and 1980s has resulted in significant long-term cardiac toxicity. In absolute terms,
the increase in cardiovascular mortality induced by radiotherapy may be substantial, as these mortality
events are relatively common.
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Studies of survivors of atomic bomb irradiation reveal a
radiation dose-related cardiovascular risk [1]. An overview
of randomised trials on the effects of radiotherapy in
breast cancer patients showed an excess mortality from
circulatory diseases, and heart disease in particular [2].
However, the real impact of radiotherapy is likely to be
underestimated in studies based on randomised control
trials, because of the highly selected nature of trial partic-
ipants, and it is important that such studies should be
complemented by findings from population-based stud-
ies.
Breast radiotherapy as practised in the 1970s and 1980s
resulted in significant myocardial exposure, and this was
higher when the left breast was treated [3]. It has been
proposed that this difference might result in greater cardi-
ovascular mortality following irradiation of the left breast
when compared with the right [3,4]. We have looked at
cardiovascular mortality more than 15 years after diagno-
sis and treatment in women diagnosed with breast cancer
in the 1970s and 1980s.
Methods
All cases of female breast cancer diagnosed between 1971
and 1988 were extracted from the database held at the
Thames Cancer Registry, a population-based register cov-
ering much of South East England. We excluded 3052 can-
cers of unknown laterality (4%) and 824 which were
bilateral (1%). Deaths from breast cancer (ICD-9 174;
ICD-10 C50), ischaemic heart disease (IHD) (ICD-9 410–
414; ICD-10 I20-I25) or any cardiovascular disease (CVD)
(ICD-9 390–459; ICD-10 I00-I99) were identified from
death certificates.
Patients were considered at risk from the date of cancer
diagnosis, but since death codes were not available prior
to 1st January 1997, only patients surviving beyond this
date contributed to the analysis. Cases were followed up
from 1st January 1997 to 31st December 2003 (or date of
death if earlier), and were assumed to be alive at the latter
time point if no notification of death had been received.
Hence there were assumed to be no losses to follow-up. A
proportional hazards regression analysis was performed,
stratified by time since diagnosis, using as the baseline
group those women with right-sided disease who did not
receive radiotherapy, and adjusting for age at diagnosis.
Further adjustments for tumour stage and socioeconomic
status (based on the income score part of the Indices of
Multiple Deprivation (IMD) [5]) had no significant effects
on the estimated hazard ratios, and are not presented.
The study was based on routine cancer registration data,
which are collected inter alia for the purpose of monitor-
ing outcomes, and hence no ethical approval was
required.
Results
A total of 20,871 women with breast cancer were included
in the analysis, of which 51% had left-sided disease. The
mean age at diagnosis was 56.3 years (standard deviation
12.4 years). Tumour stage was not known in 23% of cases.
Of those with known stage, two thirds were Stage 1 (local-
ised) and 2.4% Stage 4 (metastases). 53% received radio-
therapy. Although our data are insufficiently detailed to
enable us to distinguish between different radiotherapy
sites, we believe that the vast majority would have been to
the breast or chest wall. Table 1 compares the characteris-
tics of the four groups. There were significant differences
across the groups in relation to mean age at diagnosis,
deprivation quintile, stage and hormone therapy. How-
ever, when comparing left with right in patients with or
without radiotherapy, there were no significant differ-
ences in any of these characteristics.
The median length of follow-up was 18.5 years, and was
slightly shorter in the irradiated group (Table 1). During
the period of observation, 1688 deaths from CVD (includ-
ing 675 from IHD) were recorded, representing 8.1% and
3.2% of the study population respectively. Of these, 1023
and 426 respectively occurred more than fifteen years after
diagnosis.
Table 2 shows age-adjusted hazard ratios (HRs) and the
associated 95% confidence intervals (CIs) for deaths
occurring 15 years or more after diagnosis. Mortality was
increased in recipients of left-breast radiotherapy com-
pared to non-irradiated women with right-sided breast
cancer, both for IHD (HR 1.59; 95% CI 1.21–2.08; p =
0.001) and all CVD (HR 1.27; 95% CI 1.07–1.51; p =
0.006). There were no significant differences in breast can-
cer mortality between the groups. Those who received
radiotherapy were younger and of higher socioeconomic
status (SES), and had more advanced disease than the
non-recipients (p < 0.001 in all cases). However, adjusting
for stage and SES in addition to age made little difference
to the estimated hazard ratios.
When irradiated women with left-sided breast cancer were
compared with irradiated women with right-sided breast
cancer, cardiovascular mortality at 15+ years after diagno-
sis was raised by around 25% (IHD: HR 1.23; 95% CI
0.95–1.60; p = 0.114; CVD: HR 1.25; 95% CI 1.05–1.49;
p = 0.014).
Discussion
We report a substantial elevation in cardiovascular mor-
tality at greater than 15 years following radiotherapy to
the left breast during the 1970s and 1980s. These resultsPage 2 of 5
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practised during this period results in long-term cardiac
toxicity, and confirm for the first time in a sample of UK
patients the excess previously demonstrated in an Ameri-
can population [3].
Our findings are in general agreement with those of other
long-term toxicity studies. A Swedish study covering the
period 1970 to 1985 [6] found that breast cancer patients
with left-sided tumours had significantly higher mortality
due to myocardial infarction than patients with right-
sided tumours. An overview based on randomised trials of
radiotherapy initiated before 1975 [7] found an excess of
cardiac deaths in patients surviving at least ten years. A
more recent Dutch study [8] found that postmastectomy
radiotherapy administered prior to 1979 and between
1979 and 1986 was associated with a 2-fold and 1.5-fold
increase in cardiovascular mortality, respectively.
Table 2: Age-adjusted hazard ratios for deaths occurring 15 years or more after diagnosis of breast cancer
Time since diagnosis
Death cause Radio- therapy Side 15+ years
Hazard Ratio 95% Confidence Interval p-value Deaths
Ischaemic Heart Disease No R 1.00 - - 93
L 0.99 0.75 – 1.31 0.931 102
Yes R 1.28 0.96 – 1.70 0.092 101
L 1.59 1.21 – 2.08 0.001 130
All Cardiovascular Disease No R 1.00 - - 252
L 0.97 0.82 – 1.15 0.747 271
Yes R 1.02 0.85 – 1.23 0.806 219
L 1.27 1.07 – 1.51 0.006 281
Breast Cancer No R 1.00 - - 208
L 1.05 0.87 – 1.26 0.637 232
Yes R 1.05 0.87 – 1.27 0.600 229
L 1.16 0.97 – 1.40 0.105 265
All causes No R 1.00 - - 781
L 1.05 0.95 – 1.15 0.359 896
Yes R 1.05 0.95 – 1.16 0.321 746
L 1.16 1.05 – 1.28 0.003 856
Table 1: Characteristics of study population by radiotherapy group and laterality
No radiotherapy Radiotherapy p- value
Right Left Right Left
Age (years) Mean 58.1 58.4 54.5 54.8 < 0.001
S.D. 13.2 13.2 11.6 11.4
IMD quintile 1 1027 (21.9%) 1045 (20.8%) 1338 (24.6%) 1371 (24.0%) < 0.001
2 932 (19.9%) 1066 (21.2%) 1135 (20.9%) 1183 (20.7%)
3 890 (19.0%) 928 (18.4%) 1023 (18.8%) 1095 (19.2%)
4 979 (20.9%) 1072 (21.3%) 1007 (18.5%) 1042 (18.3%)
5 760 (16.2%) 843 (16.8%) 871 (16.0%) 936 (16.4%)
N/K 106 (2.3%) 78 (1.6%) 67 (1.2%) 77 (1.4%)
Stage 1 2557 (54.5%) 2651 (52.7%) 2677 (49.2%) 2758 (48.4%) < 0.001
2 316 (6.7%) 331 (6.6%) 566 (10.4%) 553 (9.7%)
3 523 (11.1%) 554 (11.0%) 1016 (18.7%) 1071 (18.8%)
4 103 (2.2%) 105 (2.1%) 89 (1.6%) 92 (1.6%)
N/K 1195 (25.5%) 1391 (27.6%) 1093 (20.1%) 1230 (21.6%)
Chemotherapy No 4457 (95.0%) 4804 (95.5%) 5180 (95.2%) 5443 (95.4%) 0.602
Yes 237 (5.0%) 228 (4.5%) 261 (4.8%) 261 (4.6%)
Hormone Therapy No 3445 (73.6%) 3785 (75.2%) 3904 (71.8%) 4127 (72.4%) < 0.001
Yes 1239 (26.4%) 1247 (24.8%) 1537 (28.2%) 1577 (27.6%)
Follow-up (years) Mean 20.31 20.46 19.26 19.19 < 0.001
S.D. 5.45 5.50 5.02 4.97
Median 19.57 19.73 17.94 17.86 < 0.001
Total cases 4694 5032 5441 5704Page 3 of 5
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detailed information on the radiation techniques
involved, and it is possible that these may have changed
during the period of the study. However, the lack of death
details prior to 1997 make an analysis by period of treat-
ment difficult, as period of treatment becomes aliased
with period of follow-up. For the same reasons, we have
not shown results for mortality at less than 15 years after
diagnosis.
The comparison of left vs. right in the irradiated group
used in our and other studies [3,4] is useful because ther-
apy does not depend on laterality, and bypasses the
potential problem of selection bias in a straight compari-
son of irradiated vs. non-irradiated women. As shown in
Table 1, the differences in the observed characteristics
between the irradiated and non-irradiated groups were
eliminated when comparing left vs. right irradiated
women. Whilst we were unable to obtain data on other
cardiovascular risk factors such as smoking and exercise
habits, it is unlikely that these would be related to lateral-
ity.
However, the exact quantification of the excess risk of car-
diovascular mortality is not straightforward. A contrast
between left and right sided breast cancer will tend to pro-
duce conservative estimates of risk because radiotherapy
to the right breast, especially methods involving internal
mammary lymph node (IMN) fields, also entails some
cardiac dose.
In absolute terms, the increase in cardiovascular mortality
that has been induced by radiotherapy may be substantial
because these mortality events are relatively common. A
woman who had breast cancer at the age of 50 and who
survived to the age of 65 would, in the absence of radio-
therapy, have a 22% risk of dying from cardiovascular dis-
ease in the next 20 years, up to the age of 85 (based on
mortality and population data for England & Wales from
National Statistics [9,10]). If the administration of radio-
therapy increased this level of risk by 25% (as indicated by
our left/right comparison), then the risk of cardiovascular
death would increase by some 5 percentage points to a
cumulative absolute risk of almost 30%. Moreover, mor-
tality represents the extreme of the disease spectrum and
is indicative of even higher levels of cardiovascular mor-
bidity that do not always lead to death.
All of the patients in our study were treated for breast can-
cer in the 1970s and 1980s. During this period, tech-
niques involving large fraction sizes, deep tangential fields
or direct internal mammary fields were common. Since
then, technical improvements in radiotherapy delivery
have resulted in lower cardiac dosage, and recent studies
[3,11] based on cancer registrations in the USA have
shown a decline in the long-term risk of cardiac death
after radiotherapy for breast cancer. More recent innova-
tions such as conformal and intensity-modulated radio-
therapy offer the potential of further reducing cardiac
exposure [12].
Conclusion
We have found a significant and important elevation in
cardiovascular mortality at 15+ years following radiother-
apy to the left breast. This result is consistent with the
hypothesis that radiotherapy as administered in the 1970s
and 1980s results in long-term cardiac toxicity.
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